These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9436302)

  • 21. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
    Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
    Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
    Yoon J; Yoo EA; Kim JY; Pae AN; Rhim H; Park WK; Kong JY; Park Choo HY
    Bioorg Med Chem; 2008 May; 16(10):5405-12. PubMed ID: 18456500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
    Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
    Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats.
    Mosher T; Hayes D; Greenshaw A
    Eur J Pharmacol; 2005 May; 515(1-3):107-16. PubMed ID: 15896731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
    Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of an Integrated GPCR SAR-Modeling Platform To Explain the Activation Selectivity of Human 5-HT2C over 5-HT2B.
    Heifetz A; Storer RI; McMurray G; James T; Morao I; Aldeghi M; Bodkin MJ; Biggin PC
    ACS Chem Biol; 2016 May; 11(5):1372-82. PubMed ID: 26900768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes.
    Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
    Neuropharmacology; 2004 Apr; 46(5):663-71. PubMed ID: 14996544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
    Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New 5-HT
    Fiorino F; Magli E; Kędzierska E; Ciano A; Corvino A; Severino B; Perissutti E; Frecentese F; Di Vaio P; Saccone I; Izzo AA; Capasso R; Massarelli P; Rossi I; Orzelska-Gòrka J; Kotlińska JH; Santagada V; Caliendo G
    Bioorg Med Chem; 2017 Oct; 25(20):5820-5837. PubMed ID: 28943244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of dual role of piperazine-linked phenyl cyclopropyl methanone as positive allosteric modulator of 5-HT
    Singh K; Sona C; Ojha V; Singh M; Mishra A; Kumar A; Siddiqi MI; Tripathi RP; Yadav PN
    Eur J Med Chem; 2019 Feb; 164():499-516. PubMed ID: 30622024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H; Velázquez-Martínez DN
    J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
    Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands.
    Lee M; Rangisetty JB; Pullagurla MR; Dukat M; Setola V; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1707-11. PubMed ID: 15745826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definition of a pharmacophore for partial agonists of serotonin 5-HT3 receptors.
    Daveu C; Bureau R; Baglin I; Prunier H; Lancelot JC; Rault S
    J Chem Inf Comput Sci; 1999; 39(2):362-9. PubMed ID: 10192948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of two 3D QSAR analyses. application to the study of partial agonist serotonin-3 ligands.
    Bureau R; Daveu C; Baglin I; Sopkova-De Oliveira Santos J; Lancelot JC; Rault S
    J Chem Inf Comput Sci; 2001; 41(3):815-23. PubMed ID: 11410063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational analysis of tandospirone in aqueous solution: lead evolution of potent dopamine D4 receptor ligands.
    Nishimura T; Igarashi J; Sunagawa M
    Bioorg Med Chem Lett; 2001 May; 11(9):1141-4. PubMed ID: 11354362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and 5-HT2C receptors, respectively.
    Aulakh CS; Mazzola-Pomietto P; Hulihan-Giblin BA; Murphy DL
    Neuropsychopharmacology; 1995 Aug; 13(1):1-8. PubMed ID: 8526967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.